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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYMetabolites are emerging as key mediators of crosstalk between metabolic flux, cellular signaling, and epigenetic regulation of cell fate.
We found that the nonessential amino acid L-proline (L-Pro) acts as a signaling molecule that promotes the conversion of embryonic
stem cells into mesenchymal-like, spindle-shaped, highly motile, invasive pluripotent stem cells. This embryonic-stem-cell-to-mesen-
chymal-like transition (esMT) is accompanied by a genome-wide remodeling of the H3K9 and H3K36 methylation status. Consistently,
L-Pro-induced esMT is fully reversible either after L-Pro withdrawal or by addition of ascorbic acid (vitamin C), which in turn reduces
H3K9 and H3K36 methylation, promoting a mesenchymal-like-to-embryonic-stem-cell transition (MesT). These findings suggest that
L-Pro, which is produced by proteolytic remodeling of the extracellular matrix, may act as a microenvironmental cue to control stem
cell behavior.INTRODUCTION
In recent years, a number of small molecules have been
identified that control stem cell differentiation and/or
cell reprogramming. Surprisingly, only a few metabolites
have been identified in this context, possibly because their
relevance has been underappreciated. The ‘‘physiological’’
compounds identified so far include epigenetic modifiers
or regulators of the cell energy/redox status acting onmito-
chondrial oxidative metabolism. For example, saturated
fatty acids and the acylcarnitines were shown to improve
embryonic stem cell (ESC) differentiation (Yanes et al.,
2010). Butyrate, a short-chain fatty acid, increases the effi-
ciency of cell reprogramming by inhibiting histone deace-
tylases (Mali et al., 2010). Finally, ascorbic acid (vitamin C),
a redox controller and a cofactor for histone demethylases,
is a key regulator of stem cell differentiation and reprog-
ramming (Cao et al., 2012; Esteban et al., 2010; Wang
et al., 2011; Yang et al., 2008). However, it has recently
become evident that also some naturally occurring amino
acids can regulate stem cell behavior. Indeed, it has been
shown that (1) ESC self-renewal depends on L-threonine
catabolism (Shyh-Chang et al., 2013; Wang et al., 2009)
and (2) L-proline (L-Pro) forces ESCs toward an epiblast
stem cell (EpiSC)-like state (Washington et al., 2010) and
regulates ESC metastability (Casalino et al., 2011). L-Pro
is particularly interesting because its mitochondrial oxida-Stem Celltive catabolism is linked to cell survival/cell death in cancer
cells (Liu et al., 2012; Phang et al., 2012) and to life span
extension inC. elegans (Zarse et al., 2012). Here, we provide
evidence that physiological concentrations of L-Pro are
sufficient to convert ESCs into mesenchymal-like, highly
motile, invasive pluripotent stem cells, which acquire met-
astatic potential in vivo. This previously unforeseen em-
bryonic-stem-cell-to-mesenchymal-like transition (esMT)
is fully reversible either after L-Pro withdrawal or by addi-
tion of vitamin C. Most remarkably, L-Pro extensively re-
models both the transcriptome and the epigenome, thus
acting as a potent signaling metabolite in pluripotent
stem cells.RESULTS
L-Pro Modifies ESC Morphology Inducing Extensive
Cytoskeletal Rearrangements
Mouse ESCs grow as leukemia inhibitory factor (LIF)-
dependent flat colonies in the presence of L-Pro (Casalino
et al., 2011; Washington et al., 2010). Examining different
growth conditions, we found that this L-Pro-induced
morphological transition markedly increased by lowering
the cell-plating density to 50 ESCs/cm2 (Figure S1 available
online). Notably, clonal L-Pro-induced cell (PiC) colonies
showed three distinctive zones (Figure 1A): (1) a ‘‘centralReports j Vol. 1 j 307–321 j October 15, 2013 j ª2013 The Authors 307
Figure 1. L-Pro Induces Cytoskeletal Rearrangements and Cell Motility in ESCs
(A and B) Representative photomicrographs of crystal violet (A) and Phalloidin-TRITC (B)-stained PiC and ESC colonies. Retraction fibers
(*) and leading edge lamellipodia (arrow) are indicated (A). Nuclei were stained with Hoechst. (B) The scale bars represent 100 mm.
(C) Fluorescence confocal photomicrographs of ESCs/PiCs labeled for vinculin and phalloidin (upper panels) or for b-tubulin (lower
panels). Actin stress fibers were labeled with Phalloidin-TRITC (red; [B and C]). Microtubules and focal adhesions were stained with anti-
b-tubulin (green; [C], lower panels) and anti-Vinculin (green; [C], upper panels) antibodies. Nuclei were counterstained with TO-PRO-3.
The scale bars represent 50 mm.
(D) Representative frames of time-lapse series from untreated (control) and L-Pro-treated ESCs. Images (203) were captured starting from
day 3 postplating.
(legend continued on next page)
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L-Pro Induces esMTand Epigenetic Remodelingzone’’ or ‘‘colony core’’ consisting of polygonal-shaped,
tightly adherent cells; (2) a ‘‘peripheral zone’’ at the
external margin of the colony, consisting of less-cohesive
spindle-shaped cells; and (3) a ‘‘surrounding zone,’’ form-
ing a crown of mesenchymal-like cells scattered around
the colony. These latter cells were characterized by a large
nucleus with prominent nucleoli and a highly polarized
mesenchymal shape with large and flat lamellipodial pro-
trusions extending at the leading edge and needle-like trail-
ing structures on the rear (Figure 1A). Alterations of cell
shape and the formation of lamellipodial protrusions are
primarily driven by actin cytoskeleton remodeling (Gian-
none et al., 2007; Ridley, 2011). Accordingly, we found
that mesenchymal-like PiCs displayed long and polarized
F-actin stress fibers frequently terminating in large and
mature focal adhesion complexes. Presumably, as a conse-
quence of this actin cytoskeleton-driven shape transition,
also the microtubules organized into an extended network
typical of mesenchymal motile cells (Figures 1B and 1C).
Thus, ESCs undergo a morphological transformation,
which is reminiscent of changes associated with the acqui-
sition of persistent and directional cell locomotory
properties.
L-Pro Induces a Motile Phenotype in ESCs
To test directly the possibility that L-Pro is sufficient to
induce changes in adhesive and motile properties of stem
cells, the ESC-to-PiC phenotypic transition was monitored
by time-lapse video microscopy (Figure 1D; Movies S1, S2,
and S3). Control ESCs formed compact colonies from
which, occasionally, individual cells in direct contact
with the substrate extended transient and short-lived cyto-
plasmic protrusions that appeared to direct the collective
mode of locomotion of the entire colony (Movie S1). Cell
divisions were visualized as transient swellings or ‘‘bub-
bles’’ that sporadically protruded from the colony. Within
1–3 days of plating, L-Pro-treated ESCs formed, as expected,
spherical colonies; however, by day 3 onward, single, high-
ly motile cells started to scatter, detaching from the colony
margins through the extension of highly dynamic and
prominent protrusions (Figure 1D; Movies S2 and S3).
Importantly, these now freely motile, single PiCs main-
tained the ability to divide and frequently re-established
dynamic and reversible cell-cell contacts with cells in the
colony core. Consistent with the acquisition of directed
cell motility, PiCs, but not ESCs, were able to migrate effi-
ciently through porous membranes in transwell migration(E) Average number of ESCs/PiCs migrating in 15% FBS (10.5 ± 1.5 ESC
versus 110 ± 13 PiCs).
(F) Average number of PiCs migrating in 1% FBS either alone (control)
Cyr61 (200 ng/ml). Data are mean ± SD (n = 3); *p < 0.01; **p < 0.0
See also Figure S1 and Movies S1, S2, and S3.
Stem Cellassays in response to gradients of fetal bovine serum (FBS)
or toward different chemoattractants, including epidermal
growth factor (EGF), insulin, stromal cell-derived factor-1
(SDF-1), and cysteine-rich angiogenic inducer 61 (Cyr61)
(Figures 1E and 1F). Thus, L-Pro is sufficient to promote
the transition of ESCs toward a motile mesenchymal-like
phenotype.
L-Pro Induces Remodeling of the ESC Transcriptome
To elucidate whether a diverse transcriptional program is
the basis of the morphological and motility differences be-
tween ESCs and PiCs, we compared their gene expression
profiles. We found 1,500 L-Pro-dependent, differentially
regulated protein-coding genes (Figures 2A and 2B; Table
S1). Gene ontology analysis revealed that L-Pro-regulated
genes were functionally very diverse (Figure 2C), but the
pluripotency-associated factors (Oct4, Nanog, and Sox2) re-
mained, as expected, unchanged. Interestingly, whereas
genes involved in L-Pro uptake (Slc38a2), synthesis
(Aldh18a and P5cr), or catabolism (Prodh) were not affected
(Table S1), both procollagen C-endopeptidase enhancer
(Pcolce) and dipeptidyl peptidase 4 (Dpp4/CD26), which
regulate L-Pro recycling, were significantly downregulated.
DPP4, which cleaves X-Pro dipeptides generating free
L-Pro, was the most L-Pro-repressed protease (Table S1).
In contrast, expression of the DPP4 inhibitor, glypican 3
(Gpc3), was induced. Thus, ESCs respond to increased
extracellular levels of free L-Pro by repressing genes
involved in L-Pro recycling. Remarkably, PiCs and EpiSCs
(Brons et al., 2007; Tesar et al., 2007) shared 33% of differ-
entially expressed protein-coding genes with respect to
ESCs (Figure 2D). However, Cer1, Asb4, Foxa2, Gata6,
Sox17, and Stra8, which are among the most upregulated
genes in EpiSCs, did not change in PiCs. Similarly, the
developmental pluripotency-associated genes Dppa3,
Dppa4, and Dppa5 that are repressed in EpiSCs were,
instead, expressed at comparable levels in PiCs and ESCs
(Brons et al., 2007; Tesar et al., 2007). Moreover, the tran-
scription factor Rex1 (Zfp42), which is silenced in epiblast
cells just after implantation and is strongly repressed in
EpiSCs, was only weakly downregulated in PiCs (Table
S1). Notably, immunofluorescence analysis revealed that
PiCs, like ESCs, were REX1 positive (R95%) and that
REX1 expression persisted in the mesenchymal-like PiCs
scattered around the colony (Figures S2A and S2B). These
data indicate that the morphological changes of PiCs are
likely driven by a specific transcriptional program that iss versus 33 ± 3 PiCs) or toward a FBS gradient 1%–15% (13 ± 2 ESCs
or toward EGF (50 ng/ml), insulin (5 mg/ml), SDF-1 (100 ng/ml), or
05.
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Figure 2. L-Pro Remodels the ESC Transcriptome
(A) Heat map diagram of differentially expressed genes in PiCs versus ESCs.
(B) Volcano plot showing the magnitude of differential expression [log2(fold change), x axis] compared to the measure of statistical
significance [log10(p value), y axis]. Genes with a magnitude of differential expressionR5-fold are indicated in red.
(C) Gene ontology (GO) analysis (http://david.abcc.ncifcrf.gov). Pie chart showing the most represented GO term in the microarray
analysis comparing PiCs versus ESCs. The numbers inside each pie slice show the fraction (%) of differentially expressed protein-coding
genes (Table S1) in each category.
(D) Venn diagrams describing the overlap between genes differentially expressed in PiCs versus EpiSCs or Klf2/Klf4/Klf5 (Klf2,4,5) triple
knockdown ESCs compared with control ESCs.
(E) KEGG pathway enrichment analysis; pathways related to cytoskeleton/cell motility/adhesion or cancer are highlighted in green and
blue, respectively.
See also Figure S2 and Table S1.
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Indeed, a significant set of genes regulated by L-Pro were
either transcription factors or cofactors (12%; Figure 2C;
Table S1), among them several Kru¨ppel-like factors (Klfs),
which are key regulators of cell differentiation and reprog-
ramming. Of note, whereas Klf2, Klf4, and Klf5 were all
downregulated by L-Pro, the expression of Klf6 and Klf7
increased. Interestingly, PiCs and Klf2/Klf4/Klf5 triple
knockdown ESCs (Jiang et al., 2008) shared29% of differ-
entially expressed genes (Figure 2D), thus suggesting that
modulation of Klfsmight be relevant for PiC specification.
Gene ontology analysis of the PiC expression profile
denoted a consistent overrepresentation of genes in six
Kyoto Encyclopedia of Genes and Genomes (KEGG) path-
ways, all related to cell shape and motility (Figure 2E). In
keeping with the altered cytoskeleton architecture, 9% of
L-Pro-regulated genes were structurally and/or functionally
related to the cytoskeleton, whereas 12.8% were related to
cell adhesion, cell junction, or cell motility (Figure 2C; Ta-
ble S1). In line with the idea that cell motility/invasion is
associated with extracellular matrix (ECM) remodeling,
11% of the L-Pro-regulated genes were extracellular pro-
teins, including secreted proteases, as well as modulators
of their proteolytic activity (Table S1). These significant
sets of genes regulated by L-Pro likely define the molecular
signature that is required to direct and sustain the acquisi-
tion of the PiC motile phenotype. The PiC expression
profile was also enriched in genes associated with six can-
cer-related KEGG pathways (Figure 2E; Table S1), among
which there are members of the Janus kinase/signal trans-
ducers and activator (JAK/STAT), phosphatidylinositol
3-kinase (PI3K), and mitogen-activated protein kinase
(MAPK) pathways, as well as the transforming growth fac-
tor (TGF)-beta pathway (Table S1). Collectively, these find-
ings support the possibility that L-Pro may promote the
acquisition of features typical of invasive cancer cells.
PiCs Are Invasive and Metastatic Pluripotent Stem
Cells
To directly test PiC invasiveness, we first evaluated the
effect of L-Pro on cell invasion in transwell assays. PiCs,
but not ESCs, were able tomigrate throughMatrigel-coated
transwells. More relevantly, >65% of migrating PiCs
efficiently invaded a three-dimensional-Matrigel plug
(Figure 3A). Interestingly, the migratory and invasive prop-
erties of PiCs at 500 cells/cm2 (PiCs500) were strongly
reduced compared to PiCs50 generated at clonal density,
i.e., 50 cells/cm2 (R70%; Figure S1B). This latter finding
supports the key role of the seeding density in defining
the motile PiC phenotype. Moreover, PiCs generated
from the feeder-independent E14Tg2a ESCs showed a high-
ly motile/invasive phenotype, thus ruling out the possibil-
ity of an ESC line-specific effect of L-Pro (Figure S3).Stem CellWe then asked if the migratory and invasive phenotype
of PiCs correlated with metastatic potential in vivo. To
this end, enhanced GFP (EGFP)-labeled ESCs or PiCs were
injected intravenously into immunodeficient mice. The
metastatic B16-BL6 melanoma cells were used as a positive
control. Mice were sacrificed 4 weeks after injection, and
the histology of liver and lung tissues was examined for
macroscopic abnormalities. Whereas the ESC-injected
mice showed morphologically normal tissues with no evi-
dence of tumor masses, large teratomas were clearly visible
in the lungs of PiC-injected mice (Figure 3C). Moreover,
teratomas were EGFP-positive confirming that they origi-
nated from the exogenous cells (Figure 3D). These data
provide direct evidence that PiCs have acquired metastatic
properties and indicate that L-Pro-induced stem cells
acquire two of the most decisive pathological traits of the
so-called ‘‘migrating cancer stem cells,’’ i.e., stemness and
invasiveness.
L-Pro Induces an Embryonic-Stem-Cell-to-
Mesenchymal-like Transition
Our data are also consistent with the possibility that L-Pro-
induced morphological and motility phenotypes
contribute to the acquisition of cell plasticity, likewise
canonical epithelial-to-mesenchymal transition (EMT)
(Yang and Weinberg, 2008). Thus, we hypothesized that
L-Pro might trigger an EMT-like process in ESCs, namely
an esMT. EMT is characterized by the induction of mesen-
chymal markers, such as N-cadherin (N-cad), vimentin
(Vim), andmatrixmetallopeptidase 2 (Mmp2), and the con-
current downregulation of E-cadherin (E-cad), a major
component of cell adherens junctions (Kalluri, 2009;
Thiery et al., 2009).N-cad, Vim, andMmp2were all upregu-
lated in L-Pro-treated ESCs (Figure 4A). The transcription
factor brachyury (T) was also strongly induced (Figures 4A
and 4D). Notably, the expression of T has recently been
associated with EMT during metastasis (Fernando et al.,
2010; Sarkar et al., 2012). N-cad transcripts were detected
from day 2 onward during the esMT, whereas T transcripts
were induced at day 3 (Figure 4B), in a timeframe that corre-
latedwith the onset of themotile phenotype (Figure 1D). At
the protein level, both N-CAD and T accumulated later on
(Figure 4C). E-CAD, instead, was expressed at comparable
levels in ESCs and PiCs (Figures 4E and 4F). Accordingly,
the expression of the E-cad transcriptional repressors, Snail
and Slug, were not significantly altered (Figure 4E). Never-
theless, altered trafficking and cell surface distribution of
the E-CAD protein can also contribute to its functional
downregulation (Cavallaro and Christofori, 2004). In line
with this notion, we observed a reduction of E-CADprotein
at cell-cell junctions, accompanied by an accumulation of
E-CAD in perinuclear vesicular-like compartments from
day 3 of the esMT (Figures 4G and 4H).Reports j Vol. 1 j 307–321 j October 15, 2013 j ª2013 The Authors 311
Figure 3. Invasive and Metastatic Poten-
tial of L-Pro-Treated ESCs
(A) Parallel migration (gray bars) and cell
invasion (black bars) transwell assays
measuring migration/invasion of ESCs and
PiCs toward a FBS gradient (1%–15%) ±
SDF-1 (100 ng/ml). The average number of
migrating and invading PiCs is indicated.
Data are mean ± SD; n = 3; *p < 0.05; **p <
0.001.
(B) Schematic representation of in vivo
metastasis assay. Nonobese diabetic (NOD)/
SCID mice were injected intravenously with
either EGFP-marked ESCs, PiCs (1 3 106
cells), or B16-BL6melanoma cells (23 105).
(C) Lungs (left panels) and hematoxylin and
eosin-stained lung tissue sections (right
panels) from ESC/PiC-injected mice,
showing large teratomas in two PiC-injected
mice; n = 5/group.
(D) Representative photomicrographs of
lung tissue sections showing EGFP+ PiC-
derived teratomas (white stars, upper
panel) or a B16-BL6 melanoma cell-derived
tumor used as a control (white star, lower
panel).
Scale bars represent 100 mm (C) and 500 mm
(D). See also Figure S3.
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ferentiation potential, we compared both the cardiac and
neuronal differentiation kinetics of PiCs and ESCs. Despite
the fact that PiCs, but not ESCs, expressed high levels of the
panmesodermal marker brachyury, the kinetics of cardiac
markers expression were comparable in the two lines (Fig-
ure S4A). On the other hand, whereas neuronal and glia312 Stem Cell Reports j Vol. 1 j 307–321 j October 15, 2013 j ª2013 The Amarkers displayed similar levels in PiCs and ESCs, their
kinetic of expressionwasdelayed inPiCs (Figure S4B). These
data suggest that L-Pro-induced esMT does not promote or
anticipate cardiac differentiation, whereas it slightly delays
neural differentiation. Finally, to identify critical factors
involved in the L-Pro-induced esMT, we focused our atten-
tionon the protein kinase domain-containing, cytoplasmicuthors
Stem Cell Reports
L-Pro Induces esMTand Epigenetic Remodeling(PKDCC) kinase. Pkdcc was the most highly upregulated
protein kinase-coding gene in L-Pro-treated ESCs and was
induced from day 2 onward (Figure 4I; Table S1). Pkdcc is
required for the round-to-flat shape transition of chondro-
cytes occurring during bone development (Imuta et al.,
2009) and is involved in the control of protein export
from the Golgi (Kinoshita et al., 2009). Of note, E-CAD
accumulated in the Golgi complex in PiCs (Figure 4H).
Interestingly, we observed that transient Pkdcc-silencing in-
hibited the acquisition of the flat morphology in L-Pro-
treated cells (Figure 4J). Thus, L-Pro is sufficient to promote
the esMT that is dependent, at least in part, on Pkdcc.
L-Pro Alters the Epigenetic Signature of ESCs
To gain clues as to the mechanism through which the sim-
ple exposure to a nonessential amino acid induces dramatic
changes in gene transcription and ESC behavior, we hy-
pothesized that L-Pro might act as an epigenetic modifier.
Consistent with this idea, the silencing of Jmjd1a, a H3K9
demethylase, forces ESCs toward a PiC-like phenotype,
i.e., flatmorphology, sensitivity to trypsindigestionandup-
regulation of Fgf5 and T (Loh et al., 2007). We therefore
testedwhether L-Pro is sufficient to altermethylation levels
of various critical histone lysine residues in ESCs. L-Pro
augmented the global levels of H3K9me2 and H3K9me3,
as well as the levels of H3K36me3 (Figure 5A, left panel).
In contrast, the levels ofH3K4me3andH3K27me3wereun-
altered (Figure 5A, right panel). More relevantly, L-Pro trig-
gered a genome-wide reprogramming of H3K9 and H3K36
methylation status. H3K9 methylation was significantly
altered at 16,621 sites, with the highest increase inmethyl-
ation occurring at noncoding intergenic regions of the
genome (Figures 5B, S5A, andS5B).Genes showingPiCs-en-
riched H3K9me3 occupancy at proximal and distal regula-
tory regions are reported in Figure S5C. H3K9 methylation
status changed in a significant fraction (27%) of the 1,521
L-Pro-deregulated genes (p < 0.05; Figure 5C, upper panel).
Moreover, those genes displaying amodifiedH3K9methyl-
ation status were enriched in pathways relevant for the
esMT process (Figure 5C, lower panel). Consistently, genes
downregulated in PiCs displayed an increase in H3K9me3
at regulatory regions (Figure 5D). Noteworthy, repetitive el-
ements were frequently detected at sites displaying
increased H3K9me3, suggesting an induced local hetero-
chromatin spreading into nearby genes that influences
their expression (Figure 5D). Remarkably, chromatin
immunoprecipitation sequencing (ChIP-seq) showed the
highest H3K9me3 enrichment at constitutive heterochro-
matin, i.e., pericentromeres and gene deserts, indicating
that L-Pro induces heterochromatin reorganization toward
more dense structures in the nucleus (Figures S5B and S5D).
Differentially expressed genes thatwere not altered in the
H3K9me3 profile might be regulated by additional epige-Stem Cellnetic marks. Consistently, ChIP-PCR analysis revealed a
significant enrichment of the H3K27me3-repressive mark
at promoters of L-Pro-downregulated genes (Figure S5E).
Conversely, L-Pro-upregulated genes showed reduced levels
ofH3K27me3 and increased levels of theH3K4me3-permis-
sivemark.Consistentwith a globalH3K9methylationgain,
we detected an overall increase of H3K9 methylation at
both promoter and gene body regions (Figure S5E).
We also investigated the whole-genome profile of
H3K36me3 and observed 8,648 significant peaks altered
by L-Pro treatment (Figure 5E). Intragenic regions of
differentially methylated clusters of loci were H3K36me3-
increased in PiCs relative to ESCs (Figure S5F), and a sig-
nificant fraction (41%; p < 0.05) of PiC-specific genes
showed significant H3K36me3 changes according to the
transcriptional status (Figures 5F and 5G). Notably, L-Pro
induced H3K36me3 enrichment at noncoding regions, in
line with recent evidence that H3K36me3 might promote
heterochromatin formation (Figure S5G; Chantalat et al.,
2011). Collectively, our findings support a role of L-Pro as
a genome-wide inducer of H3K9 and H3K36 methylation
in pluripotent stem cells.
Vitamin C Reverts the PiC Phenotype and Induces
H3K9 and H3K36 Demethylation
Increasing evidence indicates that demethylation ofH3K36
and H3K9 is required for an efficient somatic/pre-induced
pluripotent stem cell (iPSC) to iPSC transition (Chen
et al., 2013; Wang et al., 2011). This crucial step in cell re-
programming is controlledbyvitaminC,which is a cofactor
ofH3K9 jumonji demethylases (Wanget al., 2011) anda key
regulator of stem cell differentiation and somatic cell re-
programming (Cao et al., 2012; Esteban et al., 2010; Yang
et al., 2008). We thus tested the effect of vitamin C on the
PiC phenotype. Remarkably, vitamin C almost completely
reverted the esMT at the morphological level, promoting
a mesenchymal-like-to-embryonic-stem-cell transition
(MesT), even in the presence of L-Pro. Remarkably, vitamin
Cmimicked thephenotype causedbyL-Pro removal (Figure
6A). To rule out thepossibility that vitaminC induced selec-
tionofESCs rather thanPiC-to-ESC reversion, freshlygener-
ated PiCs (P0)were directly plated at lowdensity and the fre-
quency of domed and flat colonies was assessed in the
different culture conditions. When PiCs were plated in
the presence of L-Pro, about 10% of the colonies showed a
domed phenotype (ESCs; Figures S6A and S6B), which cor-
responds to the degree of heterogeneity observed in freshly
generated PiCs. Indeed, PiCs culture consistently display
10%–15% of domed (ESCs) and 85%–90% of flat (PiCs) col-
onies (Casalino et al., 2011). Remarkably, when PiCs were
plated either in the absence of L-Pro or in the presence of
L-Pro plus vitamin C (Figures S6A and S6B), the percentage
of domedcolonies (ESCs) increasedup to50%. Importantly,Reports j Vol. 1 j 307–321 j October 15, 2013 j ª2013 The Authors 313
Figure 4. L-Pro Induces an esMT
(A) qPCR analysis of the expression of EMT markers in L-Pro-treated versus untreated ESCs (day 5).
(B and C) Time course of N-cad and T expression measured by qPCR (B) and western blot (C) analysis. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
(D) Microphotographs of T immunostaining (left panel) and phase contrast (right panel) of PiCs. The scale bar represents 100 mm.
(legend continued on next page)
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culture conditions was comparable. Moreover, the migra-
tory and invasive properties of the vitamin C-treated PiCs
(ESCsRev) resembled the one of ESCs (Figure 6B). Finally,
both the frequency and the timing of appearance of flat col-
onies were comparable in L-Pro-treated ESCs and ESCsRev
(Figures 6C and 6D), thus ruling out the possibility that
ESCsRev were primed for PiC formation. All together these
findings provide evidence that vitamin C reverts both the
morphological and the functional phenotype of PiCs to-
ward that of ESCs. At the molecular level, vitamin C
repressed L-Pro-induced T expression and reverted L-Pro-
induced downregulation of Inhbb expression (Figure 6E).
Furthermore, vitamin C inhibited the L-Pro-induced in-
crease in H3K9me3 and H3K36me3 levels to an extent
that was comparable to that observed following L-Prowith-
drawal. Thus, vitamin C induces the MesT by remodeling
the epigenetic signature of PiCs (Figure 6F). To get insight
into the epigenetic mechanism underlying vitamin C-
induced reversion of the PiC phenotype, we knocked
down Jmjd1a. To this end, PiCs were transfected with either
shRNA constructs targeting different regions of the tran-
script (Jmjd1a- shRNA1 and shRNA2) or control shRNAs
(Jmjd1a- shRNA1mut and Luciferase shRNA), as previously
described (Loh et al., 2007). Of note, neither the
morphology nor the expression of pluripotency markers
was altered in Jmjd1aKD (R70%gene silencing; Figure S6D)
compared to controls PiCs (datanot shown).We thusplated
Jmjd1a KD and control PiCs in the presence or the absence
of vitamin C and analyzed the frequency of flat and domed
colonies. The frequency of appearance of domed colonies
was nearly identical in vitamin C-treated Jmjd1a KD and
control PiCs (Figure S6E). Notably, the effect of vitamin C
mimicked the one achieved by L-Pro removal (Figure S6E).
These data indicate that downregulation of Jmjd1a is not
sufficient to prevent vitamin-C-dependent PiC-to-ESC
reversion. Remarkably, neither glutathione nor N-acetyl-L-
cysteine were able to revert PiCs toward an ESC phenotype
(Figure S6C), thus excluding the possibility that vitamin C
acts in this process through its antioxidant activity.(E) qPCR analysis of E-cad, Snail, and Slug expression in L-Pro-treated
(F) Time course of E-CAD expression in L-Pro-treated ESCs by western b
to untreated ESCs after normalization to GAPDH.
(G) Images of E-CAD immunostaining of control and L-Pro-treated E
fluorescence microscopy. White arrow (inset) indicates the vesicular
(H) Fluorescence confocal photomicrographs showing colocalization
counterstained with Hoechst. The scale bar represents 20 mm.
(I) Time course of Pkdcc expression in L-Pro-treated ESCs by qPCR. (A
normalization to Gapdh.
(J) Downregulation of Pkdcc expression by siRNAs (left panel) in L-P
compared to control (nontargeting siRNA). Effect of Pkdcc-silencing on
colonies scored; n = 3; *p < 0.01.
See also Figure S4.
Stem CellDISCUSSION
How metabolites regulate stem cell biology represents a
major challenge and is still poorly understood. Here, we
uncover an unexpected role of L-Pro as a key regulator of
mouse ESC migratory and invasive phenotype, revealing
that L-Pro is a potent epigenetic modifier. L-Pro, and in
particular its mitochondrial catabolism, has become an
important area of study being at the crossroads of keymeta-
bolic pathways, including citric acid cycle, polyamines
biosynthesis, and urea cycle (Phang et al., 2012). Despite
that L-Pro is a nonessential amino acid (Phang et al.,
2008), we demonstrate that the addition of L-Pro in ESC
culture medium is sufficient to induce a previously unfore-
seen esMT, which converts compacted/clustered ESCs into
scattered, freely motile pluripotent stem cells. Of note, this
phenotype was not observed in previous studies (Casalino
et al., 2011;Washington et al., 2010), most likely because it
markedly increased when ESCs are seeded at clonal density
in the presence of L-Pro. Accordingly, PiCs generated at
higher density (PiCs500) showed poor migratory and inva-
sive properties compared to PiCs generated at clonal
density (PiCs50) indicating that seeding density strongly
influences the EMT-like phenotype of PiCs.
The L-Pro-induced esMT is accompanied by a global
remodeling of the ESC transcriptome, which nicely corre-
lates with the phenotypic variation observed. Indeed,
genes involved in the control of cell cytoarchitecture, adhe-
sion, and migration/invasiveness are largely affected by
L-Pro. Notably, despite this extensive remodeling of the
transcriptome, expression levels of the pluripotency-
associated factors (Oct4, Nanog, and Sox2) and the de-
velopmental pluripotency-associated gene Dppa3 (Stella)
are comparable in PiCs and ESCs. Furthermore, PiCs,
like ESCs, are REX1 (Zfp42)-positive (R95%) and show
similar in vitro differentiation kinetics. This molecular
signature and the fact that PiCs strictly depend on LIF for
self-renewal (Casalino et al., 2011) suggest that they define
a population of inner cell mass-like cells that have acquired
a motile and invasive phenotype.versus untreated ESCs (day 5).
lot analysis. Densitometric analysis of E-CAD protein levels relative
SCs using conventional (upper panels) or confocal (lower panels)
perinuclear localization of E-CAD. The scale bar represents 50 mm.
(white arrows) of E-CAD with the Golgi marker GM130. Nuclei were
, B, E, and I). Data are fold change compared to control ESCs after
ro-treated ESCs (day 5). Data are fold change in gene expression
the colony-type frequency (right panel); data are mean ± SD,100
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L-Pro Induces esMTand Epigenetic RemodelingInterestingly, L-Pro-induced esMT is accompanied by a
significant increase in H3K9 andH3K36methylation levels
as well as by a global remodeling of the H3K9me3 and
H3K36me3 marks. This L-Pro-induced esMT is fully revers-
ible either after L-Pro withdrawal or by addition of ascorbic
acid (vitamin C), promoting a MesT and inducing the
reduction of H3K9 and H3K36 methylation levels.
To the best of our knowledge, only three metabolites, L-
threonine, butyrate, and vitamin C, have been identified
so far that act as epigenetic modulators of ESC self-renewal
and/or somatic cell reprogramming (Mali et al., 2010; Shyh-
Chang et al., 2013;Wang et al., 2009). Interestingly, L-thre-
onine, which is the only amino acid among these metabo-
lites, influences H3K4me3 by controlling the abundance
of S-adenosylmethionine, leaving other lysine residues un-
altered (Shyh-Chang et al., 2013). This intriguing specificity
is also exertedbyL-Pro that conversely influences the global
level of trimethylation of lysines K9 and K36, which would
likely exert a wider effect on gene expression. This is consis-
tent with the extensive molecular and phenotypic varia-
tions induced by L-Pro onESCs, as, for instance, the striking
acquisition of motility and invasiveness. Most remarkably,
L-Pro-induced global increase of H3K9 and H3K36 trime-
thylation preferentially occurs at noncoding intergenic
regions and constitutive heterochromatin. Whereas
H3K9me3 is a well-known repressive heterochromatic
mark, the H3K36me3 deposition within heterochromatin
domains has only recently emerged. H3K36me3 might
thus contribute to the establishment of a transcriptionally
unfavorable chromatin conformation by recruiting repres-
sive complexes (Chantalat et al., 2011). Our data suggest
that L-Pro can induce heterochromatization, increasing
H3K9me3 and H3K36me3 especially at pericentromeric
and gene desert regions, and imply that there is a hierarchy
of target chromatin regions and associated noncoding ele-
ments that are more sensitive to the effect of L-Pro in ESCs.
Thus, our findings add to the emerging evidence that me-
tabolites are key mediators of epigenetic regulation of stemFigure 5. L-Pro Modifies the Epigenomic Signature of ESCs
(A) Western blot analysis of global H3K9 mono-, di-, and trimethylatio
compared to ESCs. Densitometric analysis is relative to control ESCs a
*p < 0.05; **p < 0.001.
(B) Genome-wide H3K9me3 peaks (upper panel) and SICER-based diffe
and intergenic regions in PiCs versus ESCs.
(C) Venn diagram correlating microarray gene expression and ChIP-s
enrichment analysis of 439 loci that are H3K9me3 differentially enric
(D) Snapshot of H3K9me3 profile at Smarcad1, Apod, and Ceacam1 ge
(E) Genome-wide H3K36me3 peaks (upper panel) and SICER-based di
genic and intergenic regions in PiCs versus ESCs.
(F) Venn diagram correlating microarray gene expression and ChIP-seq
enrichment analysis of 628 loci that are H3K36me3 differentially enr
(G) Snapshot of H3K36me3 profile at Pitx2, Fgf5, and Pkdcc genes.
See also Figure S5 and Table S2.
Stem Cellcell fate and strengthen the role of the amino acids in this
process. Yet how metabolites control chromatin modifiers
in space and time, translating a dynamic metabolic state
intoahistonecode, is still a keyunresolvedquestion (Folmes
et al., 2012; Phang et al., 2013; Sassone-Corsi, 2013; Zhang
et al., 2012). Interestingly, it has been recently proposed
that theconcentrationofmetabolites and their biosynthetic
enzymesmay localize to chromatin subdomains promoting
the clustering of relevant DNA andhistonemodifications at
specificgenomic loci (Katadaet al., 2012). It is thus tempting
to speculate that specific histone-modifying enzymesmight
sense the presence of L-Pro and eventually translate this
signal into different histone maps. Interestingly, we have
shown that vitamin C, which is a cofactor of the Jumonji-
family histone demethylases, antagonizes the effect of
L-Pro on H3K9me3 and H3K36me3 levels. Of note, knock-
down of Jmjd1a (H3K9 demethylase) does not prevent
vitamin C-induced PiC-to-ESC reversion. However, because
many other vitamin C-regulated histone modifier enzymes
might be involved in this process, further studies areneeded
to reveal its molecular nature.
We believe that our findings have several implications for
stem cell biology. First, it has been shown that the
reprogramming process initiates through a mesenchymal-
to-epithelial transition (MET) (Li et al., 2010; Samavarchi-
Tehrani et al., 2010) and that vitamin C-dependent
decrease of H3K9/H3K36 methylation levels promote
somatic/pre-iPSC to iPSC transition (Chen et al., 2013;
Wang et al., 2011). Thus L-Pro and vitaminC exert opposite
effects on H3K9 and H3K36 methylation status, regulating
antagonistic cellular processes relevant for cell reprogram-
ming. Recently, it was reported that vitamin C also pro-
motes Tet-mediated DNA demethylation (Blaschke et al.,
2013). It will be thus interesting to investigate the effect
of L-Pro on DNA methylation.
Second, the L-Pro/vitamin C-regulated esMT-MesT
switch is reminiscent of the transient EMT-MET switch
that has been proposed as a driving force of metastasis,n (left) and H3K4, K27, and K36 trimethylation (right) levels in PiCs
fter normalization to total histone H3. Data are mean ± SD (n = 3);
rential distribution (lower panel) of H3K9me3 binding sites at genic
eq data (p = 0.03; Fisher’s exact test; upper panel). KEGG pathway
hed and deregulated (lower panel).
nes.
stribution (lower panel) of differential H3K36me3 binding sites at
data (p = 0.03; Fisher’s exact test; upper panel) and KEGG pathways
iched and deregulated (lower panel).
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Figure 6. Vitamin C Reverts the PiC Phenotype Inducing H3K9 and H3K36 Demethylation
(A) Schematic representation of the experimental strategy. Freshly generated PiCs (P0) were passaged twice (P1 and P2) with L-Pro
(control), without L-Pro, or with L-Pro + VitC. Cells were then plated at 500 cells/cm2, grown for 5 days, and processed for colony
phenotype assay (domed versus flat; right panel). Data represent the percentage of colony-type frequency and are mean ± SD; 100
colonies scored; n = 3.
(B) Migration (white bars) and cell invasion (gray bars) transwell assays of ESCs, PiCs, and vitamin C-treated PiCs (ESCsRev) toward a FBS
gradient (1%–15%). The average number of migrating and invading cells is indicated. Data are mean ± SD; n = 3; *p < 0.01; **p < 0.0001.
(C and D) Comparative analysis of L-Pro-induced phenotypic transition in ESCsRev and ESCs. (C) Flat colony frequency of control (untreated)
and L-Pro-treated ESCs and ESCsRev at days 4 and 5 after plating. Data are mean ± SD (n = 3; 100 colonies were scored in each exper-
iment). (D) Time course analysis of PiC formation in L-Pro-treated ESCs versus ESCsRev. Representative photomicrographs of crystal violet-
stained, L-Pro-treated ESCs and ESCsRev colonies at the indicated time points. The scale bars represent 50 mm.
(E) qPCR analysis of T and Inhbb expression. Data are fold change in gene expression compared to control (+L-Pro) after normalization to
Gapdh.
(F) Western blot analysis of H3K9me3 and H3K36me3 levels (lower panels). Densitometric analysis (upper panels) is relative to control ESCs
after normalization to total histone H3. Data are mean ± SD (n = 2); *p < 0.05; **p < 0.01.
See also Figure S6.
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L-Pro Induces esMTand Epigenetic Remodelinglargely influenced by microenvironment (Brabletz et al.,
2005). Indeed, it is proposed that induction of EMTconfers
migrating properties to cancer stem cell (Brabletz, 2012).
How this occurs is still poorly defined. Interestingly, the
ECM is mostly composed of collagen (80%) and is consid-
ered as a reservoir of mobilizable L-Pro (Phang et al.,
2008). Here, we suggest that L-Pro, which is released from
ECM degradation during tumor invasion, may act as envi-
ronmental cue of the EMT to control tumor dissemination.
Moreover, L-Pro metabolism is dysregulated in cancer (Liu
et al., 2012; Phang et al., 2012) and L-Pro synthesis is asso-
ciated with tumor progression and aggressiveness (Scott
et al., 2011), yet the mechanisms remain largely unsolved.
Althoughmuchwork remains to be carried out to assess the
in vivo relevance of L-Pro as signal molecule, our findings
contribute to elucidating its role in regulating stem cell
behavior and provide insights into the mechanisms by
which metabolites control stem cell fate.EXPERIMENTAL PROCEDURES
Cell Cultures
Wild-type TBV2 (129/SvP), b-actin/EGFP TBV2 and E14Tg2a (E14)
mouse ESCs were cultured as described (Casalino et al., 2011). PiCs
were generated as previously described (Casalino et al., 2011).
Briefly, ESCs were seeded at low density (50–500 cells/cm2) and
grown in the presence of L-Pro (50–500 mM) for 5 days. Freshly
generated PiCs (P0) consistently displayed 10%–15% of domed
(ESCs) and 85%–90% of flat (PiCs) colonies. ESC treatment details
are reported in the Supplemental Experimental Procedures. B16-
BL6 melanoma cells were cultured in RPMI, 10% FBS, 2 mM gluta-
mine, and 100 U/ml penicillin/streptomycin.
In Vitro Differentiation
For cardiomyocyte differentiation, ESCs/PiCs were allowed to
differentiate through embryoid bodies in hanging drop (500
cells/drop) as described (Parisi et al., 2003). Neuronal differentia-
tion was performed as described (Fico et al., 2008).
Pkdcc Silencing
ESCs were plated at 50 cells/cm2 in the presence of L-Pro (150 mM)
and transfected twice, at 30 and 54 hr after plating, with Pkdcc
siRNAs or control (150 nM; Silencer Select siRNA; Ambion)
using Lipofectamine RNAiMAX (Invitrogen). tBLOCK-iT Alexa
Fluor Red (50 nM; Ambion) was used to assess the transfection
efficiency.
Jmjd1a Silencing
PiCs were transfected with 2 mg of DNA plasmids (Loh et al., 2007)
using Lipofectamine 2000 (Invitrogen). Puromycin (1 mg/ml;
Sigma) selection started 1 day after transfection and was main-
tained for 3 days. Puromycin-resistant cell pools were either har-
vested for RNA extraction or plated at low density without L-Pro
or with L-Pro ± vitamin C (VitC) (500 mM) and the resulting col-
onies analyzed at day 5 after plating.Stem CellRNA Preparation and Quantitative RT-PCR
Total RNAswere isolated using RNeasymini kit and analyzed at the
Ohio State Universitymicroarray facility. QuantiTect Reverse Tran-
scription kit (QIAGEN) and SYBR Green PCR master mix (Fluo-
Cycle II SYBR; EuroClone) were used for quantitative PCR (qPCR)
analysis. Primers are in the Supplemental Experimental
Procedures.
Cell Migration/Invasion and Metastasis Assays
Migration assays were performed using polycarbonate (5 mm pore;
Costar) or polyester membrane transwells (8 mm pore; BD Biosci-
ences). ESCs were plated at 50 or 500 cells/cm2 in complete me-
dium ± L-Pro. At day 5, cells were detached with Accutase (Sigma)
and 2 3 104 ESCs/PiCs were incubated for 20–22 hr. EGF, insulin,
SDF-1 (Sigma-Aldrich), and Cyr61 (R&D Systems) were added in
1% FBS. Invasion assays were performed using BD BioCoat Growth
Factor Reduced MATRIGEL Invasion Chambers (Supplemental
Experimental Procedures).
EGFP-marked ESCs were plated at 50 cells/cm2 and grown in
complete medium ± L-Pro for 5 days. ESCs/PiCs (1 3 106 cells)
and B16-BL6 (2 3 105) were injected into the tail veins of 7-/8-
week-old severe combined immunodeficiency (SCID) mice (five
mice/group; Charles River Laboratories). ESCs/PiCs were also in-
jected subcutaneously as control. After 4 weeks, mice were sacri-
ficed and paraformaldehyde-perfused tissues were explanted and
photographed (Leica MZ16 FA stereomicroscope) before embed-
ding in optimal cutting temperature. The care and husbandry of
mice and metastasis experimental procedures were in accordance
with European Directives No. 86/609 and with Italian D.L. 116
and approved by the Institute of Genetics and Biophysics (IGB)
veterinarian.
Time-Lapse Experiments
ESCs were seeded on gelatin-coated plates at 50 cells/cm2 and
grown in complete medium ± L-Pro (150 mM). Images were
captured (203) every 5 min for about 24 hr using Nikon Eclipse
TE2000-E inverted microscope.
Immunofluorescence Analysis
Cells were fixed (4% paraformaldehyde) and permeabilized (0.1%
Triton X-100) at room temperature. After incubation with the
primary antibodies (Supplemental Experimental Procedures),
cells were incubated with the appropriate secondary antibodies
(Alexa Fluor 1:200; Molecular Probes). Phalloidin-TRITC (1:300;
Sigma) was used for actin staining. For REX1 immunofluores-
cence, 1–1.5 3 104 ESCs/PiCs were centrifuged at 900 rpm for
15 min (Cytocentrifuge; Thermo Scientific). Cytospin samples
were processed as above. Images were taken using inverted
(DMI6000B; Leica Microsystems) and confocal (TCS-SP2-AOBS;
Leica Microsystems) microscopes. Leica FW4000 and AF6000 soft-
ware were used for image acquisition/elaboration.
Western Blot Analysis
Cell lysates were prepared with ice-cold radio immunoprecipita-
tion assay (RIPA) lysis buffer. Cell pellets were resuspended in
Triton buffer for histone extraction. Primary antibodies are re-
ported in the Supplemental Experimental Procedures. DetectionReports j Vol. 1 j 307–321 j October 15, 2013 j ª2013 The Authors 319
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(Amersham Biosciences). Densitometric analysis was carried out
using the software GelEval 1.35.ChIP-qPCR and -Sequencing
Chromatin immunoprecipitation was performed as previously
described (De Bonis et al., 2006). Suitable amount of chromatin
was incubated with 5–10 mg of the indicated antibodies (Supple-
mental Experimental Procedures). Immunoprecipitated com-
plexes were recovered with protein A sepharose (Pharmacia),
washed with low and high salt buffers, reverse-crosslinked, and
purified. Primers are reported in the Supplemental Experimental
Procedures. The statistical significance of the qPCR results was as-
sessed using the Student’s t test.
H3K9me3 and H3K36me3 immunoprecipitated samples were
prepared for SOLiD System 4.0 (Applied Biosystems)-based
sequencing. Mapping to the mouse reference genome and peak-
finding software are reported in the Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The Gene Expression Omnibus accession numbers for microarray
and ChIP-seq data are GSE50603 and GSE50477, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, two tables, and three movies and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2013.09.001.
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